Statistics
Publications
6
Citations
566
H-Index
6
Active since
1956
KW Johnson is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuropharmacology.
Publications per year
1956–2004
6
6
LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine
CN Sang, NM Ramadan, RG Wallihan et al. · Cephalalgia · 2004 · 173 citations
Goldstein Dj, KI Roon, WW Offen et al. · The Lancet · 2001 · 171 citations
Medicine, Neurology, Pharmacology +11
Lanepitant, an NK-1 Antagonist, in Migraine Prevention
Goldstein Dj, WW Offen, EG Klein et al. · Cephalalgia · 2001 · 130 citations
ML Cohen, KW Johnson, KW Schenck et al. · Cephalalgia · 1997 · 30 citations
1–5 of 6